Free Newsletter
Teva workers were WARNed of layoffs last May
Teva Pharmaceuticals spokeswoman Denise Bradley points out that although 70 workers at the company's Irvine, CA, facility received pink slips, as we reported Tuesday, they had received WARN notices back in May, when the company announced its exit from the propofol business. WARN stands for the Worker Adjustment and Retraining Notification, a federal requirement that employers provide 60 days' notice of mass layoffs.
Bradley says via email that the employees who were let go received both severance and outplacement services.
The facility, which is currently in voluntary shut-down mode while the company works on process improvements, is the manufacturing home of some 50 injectable products. It was the subject of an FDA warning letter last December for a 13-item list of GMP violations.
Several hundred people still work there, she says. And the company expects to resume production "in the near future."
- here's a WARN fact sheet
Related Articles:
Teva axes 70 with propofol exit
Teva to stop making propofol
Teva Truck: Top 10 Pharma Cargo Thefts
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: